Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach.

Clinical neuropathology - 1 Jan 2000

Bieńkowski Michał, Wöhrer Adelheid, Moser Patrizia, Kitzwögerer Melitta, Ricken Gerda, Ströbel Thomas, Hainfellner Johannes A

Abstract excerpt

Typing of diffuse gliomas according to the WHO 2016 Classification of Tumors of the Central Nervous System is based on the integration of histology with molecular biomarkers. However, the choice of appropriate methods for molecular analysis and criteria for interpretation of test results is left to each diagnostic laboratory. In the present study, we tested the applicability of combined immunohistochemistry,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Deletion

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Molecular Diagnostic Techniques

Share to Neoplasm Grading

Share to Promoter Regions, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 29923492
DOI: 10.5414/NP301110
PMCID: PMC6102559

Genes

IDH1
TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach.PMID 29923492Read ↗

Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting.Semantic proximity Read ↗

Clinical implications of molecular analysis in diffuse glioma stratification.Semantic proximity Read ↗

Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylationSemantic proximity Read ↗

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnosticsSemantic proximity Read ↗

Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas.Semantic proximity Read ↗

Rapid Diagnosis of Adult-type Diffuse Glioma using a Layered SchemeSemantic proximity Read ↗

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnosticsSemantic proximity Read ↗

Prognostic Impact of TERT Promoter Mutations in Adult-Type Diffuse Gliomas Based on WHO2021 CriteriaSemantic proximity Read ↗

Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.Semantic proximity Read ↗

A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic ApplicationsSemantic proximity Read ↗

Clinicopathological and Molecular Profiling of Adult-Type Diffuse Glioma Using Immunohistochemistry and Real-Time Polymerase Chain Reaction: Study from a Tertiary Care Cancer Center in Western India.Semantic proximity Read ↗

Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and AdvancesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.